Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 22 for “"preserved systolic function"”.
-
Clinical characteristics of patients with heart failure and preserved left ventricular systolic function: a descriptive cohort study and comparison with heart failure and reduced systolic function
… this work, the syndrome of heart failure with preserved systolic function was a neglected area in clinical cardiovascular research. The aim of this study was to improve our understanding of this condition by investigating the prevalence of HF-PSF in a cohort of patients admitted to hospital …
-
Sex-specific cardiac remodeling and functional recovery : insights into proteomic mechanisms
… and steroid profiling to connect cardiac function with underlying molecular changes.<br>Following isoproterenol-induced myocardial injury, male and female rats showed comparable histological damage but distinct functional responses. Males developed greater systolic dysfunction and loss of …
-
GRK5 IS A NOVEL REGULATOR OF FIBROBLAST ACTIVATION AND CARDIAC FIBROSIS
… after ischemic injury as they presented with preserved systolic function, decreased fibrosis, and decreased hypertrophy compared to NLCs. Mechanistically, we show that nuclear translocation of GRK5 is involved in fibroblast activation. Conclusions: We present novel data demonstrating that GRK5 …
-
Η συσχέτιση της νεφρικής λειτουργίας με τη πίεση στο αρτηριακό δέντρο και την κεντρική φλεβική πίεση σε ασθενείς που υποβάλλονται σε στεφανιογραφικό έλεγχο
… volume and arterial blood pressure to renal function parameters. Subsequently, we tested the hypothesis that right ventricle and left ventricle hemodynamic parameters could predict all-cause mortality in our non-HF subjects. Methods: Between October 2009 and November 2010, 151 consecutive …
-
PERM1-Mediated Metabolic Crosstalk Between the Heart and Skeletal Muscle in Pressure Overload-Induced Heart Failure
… unintentional weight loss due to cardiac dysfunction– serves as an independent predictor of mortality. The early stage of cachexia involves a vicious cycle between the heart and skeletal muscle driven by metabolic dysregulation; however, its underlying bioenergetics remain unclear. PERM1, a …
-
PIEZO1 Channel-Mediated Mechanotransduction as a Driver of Cardiac Remodelling
… measurements to evaluate both structural and functional outcomes. I did immunohistochemistry and cytokine arrays to characterise fibroblast-immune crosstalk. I isolated Piezo1-WT and Piezo1-KO mouse cardiac fibroblasts, then performed mechanical stretch, whole-cell patch-clamp, and LC-MS/MS …
-
Role Of Aldehyde Dehydrogenase 2 (aldh2) In The Decrease In Coronary Angiogenesis In Type 2 Diabetes Mellitus: Identifying Novel Signaling Pathways
… in diabetes-induced heart failure with preserved ejection fraction (HFpEF). 4-hydroxy-2-nonenal (4-HNE), a reactive aldehyde that is increased in diabetic hearts, contributes to CEC dysfunction and cardiotoxicity. Aldehyde dehydrogenase (ALDH) 2, a mitochondrial enzyme that detoxifies …
-
Sex dimorphism in the cardiometabolic effects of the smoothelin-like 1 protein deletion in an ageing mouse model
… myogenic response, endothelial barrier function, and inflammatory responses. Vascular function is known to reciprocally influence cardiac function, with impaired diastole and left ventricular (LV) stiffness causally linked to endothelial dysfunction and coronary microvascular …
-
Sialylation and Cardiomyocyte Complex <i> N </i> -Glycosylation Protect Against Dilated Cardiomyopathy and Heart Failure
… of sialylation and N-glycosylation in cardiac function. Partial reduction of N-α2,3-sialylation achieved through ST3Gal4 deletion (ST3Gal4-/-) led to adult late-onset DCM. The DCM symptoms progressed gradually, developing thinner left ventricular walls and dilation of all four chambers by …
-
Role of Ataxia Telangiectasia Mutated Kinase in Western-type Diet-induced Cardiac Outcomes under Basal and Ischemic Conditions
… rapid body weight gain and preload-associated dysfunction, while WT mice displayed afterload-associated dysfunction 14 weeks post-WD. Myocyte apoptosis and hypertrophy were higher in hKO-WD versus WT-WD. WD increased fibrosis, and expression of collagen-1α1, MMP-2 and MMP-9 only in WT-WD. AMPK …
-
ATP delivery rates in myocardial hypertrophy
… secondary to severe aortic stenosis with preserved ejection fraction (SevAS-pEF) or secondary to severe primary mitral regurgitation (MR), participants with hearts adapted to exercise training, and participants with no hypertrophy (NH). It also aims to understand why some hearts transition …
-
Απεικονιστική μελέτη της διατατικής μυοκαρδιοπάθειας σε ασθενείς με διαβήτη τύπου 2 με δυναμική υπερηχοκαρδιογραφία αντίθεσης και δυναμική μαγνητική τομογραφία καρδιάς
… of this disease, which deteriorates as systolic dysfunction progresses.Background: Diabetic cardiomyopathy is characterized by microvascular disease and interstitial fibrosis, which lead to progressive heart failure; however, its pathogenesis remains uncertain. Modern non-invasive …
-
Investigations into heart failure: Cardiac and renal pathophysiology in a rodent model for HFpEF under treatment with a soluble guanylyl cyclase stimulator
… symptoms, heart failure with reduced and preserved ejection fraction (HFrEF and HFpEF) can be distinguished with diminished EF of ≤ 40% or preserved EF ≥ 50%, respectively. Diastolic dysfunction, increased left ventricular (LV) filing pressure and remodelling are characteristic in HFpEF. A …
-
Συμβολή του Β-νατριουρητικού πεπτιδίου στη διαφορική διάγνωση της δύσπνοιας σε ασθενείς με δεξιά ή αριστερή καρδιακή ανεπάρκεια
… biochemical markers, echocardiography and lung function tests. The results showed abnormal values of A. lung function tests (FEV1%, FVC%, TLC%, Tiffeneau, PaO₂ and P(A-a)O₂). B. Echocardiographic performance (LAD, RVSP, RVID, E/A transmitral flow, ASH). C. Biochemical markers (NT-ProBNP serum …
-
The nature of cachexia in patients with heart failure and stable coronary artery disease
… - patients with HF, reduced left ventricular systolic function and cachexia, n=10; 2) HF-no cachexia - those with HF, reduced systolic function but no cachexia, n=20; and 3) CAD - those with CAD, no symptoms of HF and preserved systolic function, n=10. The other subject groups were: 4) IDCM - …
-
The stress radionuclide assessment of diastolic function
… suspected heart failure and are found to have preserved systolic function. These patients may be labelled as having normal ejection fraction or diastolic heart failure, the diagnosis of which is both controversial and difficult. Previous work has identified a large proportion of these patients …
-
Cardiovascular 11β-HSD1: its role in myocardial physiology and pathophysiology
… to have smaller, lighter hearts but unaltered systolic function. Moreover, a single nucleotide polymorphism (SNP) in the Hsd11b1 gene has been associated with reduced left ventricular mass in humans, suggesting a role for 11β-HSD1 in regulating cardiac size. After myocardial infarction (MI), …
-
The effects of obesity and weight loss in heart failure: imaging the obesity paradox using magnetic resonance imaging and spectroscopy
<p>Obesity and cardiovascular function are closely linked on a number of different levels, from the impact of the whole-body complications of obesity, to the geometric remodelling inflicted on the heart and vasculature by increased body weight, to the influence of the endocrine state of the body on …
-
Stroke and the heart: A focus on atrial fibrillation and heart failure
… performed in patients with heart failure and preserved ejection fraction (HF-PEF). Stroke incidence has not significantly declined over time in patients with HF-REF enrolled to trials, despite greater use of evidence-based heart failure and oral anticoagulant therapies. However, …
-
Mechanisms underlying low flow-low gradient aortic stenosis
… varies extensively in terms of geometry and function between the AS subtypes. Therefore, it is increasingly being acknowledged that severe AS phenotypes, in particular the paradoxical LFLGs-AS, follow different antecedent pathological pathways rather than being an end-stage high-gradient …
Page 1 of 2